Fennec Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Fennec Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Fennec Pharmaceuticals Inc
Rating: 1.10715275
Author: Trendlyne DVM scores

Momentum Trap

about

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

10.91 0.29 (2.73%)

93.10% Gain from 52W Low

132.9K

XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Low Financial Strength

11.1 / 100

Expensive Valuation

12.0 / 100

Technically Neutral

54.4 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 62%

6 analysts

Fennec Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Fennec Pharma Inc Live Stock Price Today, Share Analysis and Chart

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...

93.10% Gain from 52W Low

SWOT Analysis

Fennec Pharma Inc Live Price Chart

Fennec Pharma Inc Live Price Chart